Previous Close | 10.34 |
1-Year Change | 67.59% |
6-Months Change | 35.87% |
3-Months Change | 50.29% |
Moving Avg (50d) | 10.263 |
Moving Avg (200d) | 7.653 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 422.2M |
Beta (3-Years) | 0.94 |
Revenue Growth (ttm) | -13.06% |
Net Profit Margin (ttm) | -78.44% |
Return On Assets (ttm) | -77.08% |
EPS (ttm) | -5.57 |
PE Ratio (ttm) | -1.86 |
Dividend Yield | % |
Asset Description: | AngioDynamics, Inc. |
Predicted Direction: | Sell |
Signal Strength: | Sell |
Forecast Date: | 2025-02-03 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
10.547 | 10.857 | 11.064 | 11.374 | 11.891 | 12.408 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Health Care Supplies |
Country: | United States |